Teleflex Incorporated
NYQ: TFXLive Quote
📈 ZcoreAI Score
Our AI model analyzes Teleflex Incorporated's price action across multiple timeframes using regression channels and statistical scoring.
Get TFX Z-Score →About Teleflex Incorporated
Healthcare
Medical Instruments & Supplies
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
📊 Fundamental Analysis
Teleflex Incorporated demonstrates a profit margin of -45.4%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is 1.6%, which suggests room for improvement in capital utilization.
At a current price of $118.39, TFX currently sits at the 47th percentile of its 52-week range (Range: $100.18 - $138.93).
💰 Valuation Insight
TFX trades at a 261.5% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$5.23B
Trailing P/E
90.37
Forward P/E
11.68
Beta (5Y)
0.83
52W High
$138.93
52W Low
$100.18
Avg Volume
917K
Day High
Day Low